Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
- Mrinal Gounder
- Patrick Schöffski
- Robin L. Jones
- Silvia Stacchiotti
- George D. Demetri
- Gregory M. Cote
- Mark Agulnik
- Rashmi Chugh
- Thierry Jahan
- Abha A. Gupta
- Tom Wei-Wu Chen
- Ravin Ratan
- Palma Dileo
- Alexander Drilon
- Gabriel G. Malouf
- Attila Szanto
- Neal Gupta
- Nizar M. Tannir
2026-03-25